Public signalCompany raiseAuto-indexed · Unverified

OrisDx Inc. raised $2.8M

OrisDx Inc.· CHICAGO, US· Biotechnology· Filed Jul 16, 2025

OrisDx Inc. reported raising capital. Based in CHICAGO, ILLINOIS, US. First sale reported 2025-05-23. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$2.8M
Confidence90%
Raised
$2.8M
Investors
25
Incorporated
2022
Jurisdiction
DELAWARE

On the record

Location
CHICAGO, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$2.8M
Target amount
$4.0M
Filing date
Jul 16, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2022
Industry group
Biotechnology
Number of investors
25
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$4.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 2,844,388 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jul 16, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$1M – $10MCompany Raise

Are you associated with OrisDx Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record